Literature DB >> 8421294

Structural determinants of haloenol lactone-mediated suicide inhibition of canine myocardial calcium-independent phospholipase A2.

L A Zupan1, R H Weiss, S L Hazen, B L Parnas, K W Aston, P J Lennon, D P Getman, R W Gross.   

Abstract

Haloenol lactones are potent mechanism-based inhibitors of a novel class of calcium-independent phospholipases A2 which have been implicated as the enzymic mediators of membrane dysfunction during myocardial ischemia (Hazen, S. L.; et al. J. Biol. Chem. 1991, 266, 7227-7232). Herein we demonstrate that the ring size, hydrophobic group, and cryptic electrophile in the haloenol lactone moiety are important and modifiable determinants of the inhibitory potency of haloenol lactone-mediated inhibition of calcium-independent phospholipase A2. Direct comparisons between haloenol lactone-mediated inhibition of calcium-independent phospholipase A2 and the absence of inhibition with calcium-dependent phospholipase A2 further underscore the marked differences in the catalytic strategy employed by these two classes of intracellular phospholipases A2.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8421294     DOI: 10.1021/jm00053a012

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  12 in total

1.  A bromoenol lactone suicide substrate inactivates group VIA phospholipase A2 by generating a diffusible bromomethyl keto acid that alkylates cysteine thiols.

Authors:  Haowei Song; Sasanka Ramanadham; Shunzhong Bao; Fong-Fu Hsu; John Turk
Journal:  Biochemistry       Date:  2006-01-24       Impact factor: 3.162

Review 2.  Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention.

Authors:  Edward A Dennis; Jian Cao; Yuan-Hao Hsu; Victoria Magrioti; George Kokotos
Journal:  Chem Rev       Date:  2011-09-12       Impact factor: 60.622

3.  Human pancreatic islets express mRNA species encoding two distinct catalytically active isoforms of group VI phospholipase A2 (iPLA2) that arise from an exon-skipping mechanism of alternative splicing of the transcript from the iPLA2 gene on chromosome 22q13.1.

Authors:  Z Ma; X Wang; W Nowatzke; S Ramanadham; J Turk
Journal:  J Biol Chem       Date:  1999-04-02       Impact factor: 5.157

4.  Phospholipase A2-catalyzed hydrolysis of plasmalogen phospholipids in thrombin-stimulated human platelets.

Authors:  Caroline S Beckett; Pamela J Kell; Michael H Creer; Jane McHowat
Journal:  Thromb Res       Date:  2006-10-18       Impact factor: 3.944

5.  Studies of phospholipid metabolism, proliferation, and secretion of stably transfected insulinoma cells that overexpress group VIA phospholipase A2.

Authors:  Z Ma; A Bohrer; M Wohltmann; S Ramanadham; F F Hsu; J Turk
Journal:  Lipids       Date:  2001-07       Impact factor: 1.880

6.  Group VIA PLA2 (iPLA2β) is activated upstream of p38 mitogen-activated protein kinase (MAPK) in pancreatic islet β-cell signaling.

Authors:  Haowei Song; Mary Wohltmann; Min Tan; Shunzhong Bao; Jack H Ladenson; John Turk
Journal:  J Biol Chem       Date:  2011-12-22       Impact factor: 5.157

7.  Activation of group IVC phospholipase A(2) by polycyclic aromatic hydrocarbons induces apoptosis of human coronary artery endothelial cells.

Authors:  Patricia K Tithof; Sean M Richards; Mona A Elgayyar; Fu-Minn Menn; Vijay M Vulava; Larry McKay; John Sanseverino; Gary Sayler; Dawn E Tucker; Christina C Leslie; Kim P Lu; Kenneth S Ramos
Journal:  Arch Toxicol       Date:  2010-12-04       Impact factor: 5.153

8.  Inhibition of endosome fusion by phospholipase A2 (PLA2) inhibitors points to a role for PLA2 in endocytosis.

Authors:  L S Mayorga; M I Colombo; M Lennartz; E J Brown; K H Rahman; R Weiss; P J Lennon; P D Stahl
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

9.  Smooth muscle cell arachidonic acid release, migration, and proliferation are markedly attenuated in mice null for calcium-independent phospholipase A2beta.

Authors:  Sung Ho Moon; Christopher M Jenkins; David J Mancuso; John Turk; Richard W Gross
Journal:  J Biol Chem       Date:  2008-10-16       Impact factor: 5.157

10.  Mechanism-based inhibition of iPLA2β demonstrates a highly reactive cysteine residue (C651) that interacts with the active site: mass spectrometric elucidation of the mechanisms underlying inhibition.

Authors:  Christopher M Jenkins; Jingyue Yang; Richard W Gross
Journal:  Biochemistry       Date:  2013-06-10       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.